- Home
- SID vs DYN Comparison
SID vs DYN Comparison
Compare SID & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SID | DYN |
|---|---|---|
| Founded | 1941 | 1984 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 3.1B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SID | DYN |
|---|---|---|
| Price | $1.65 | $19.91 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | $1.40 | ★ $40.00 |
| AVG Volume (30 Days) | 2.7M | ★ 3.5M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,522,708,358.00 | N/A |
| Revenue This Year | $4.33 | N/A |
| Revenue Next Year | $0.29 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.02 | N/A |
| 52 Week Low | $1.24 | $6.36 |
| 52 Week High | $1.84 | $26.22 |
Technical Indicators
Market Signals| Indicator | SID | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 51.00 |
| Support Level | $1.71 | $18.43 |
| Resistance Level | $1.78 | $19.86 |
| Average True Range (ATR) | 0.07 | 1.42 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 26.42 | 29.60 |
Price Performance
Historical ComparisonAbout SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.